These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38848944)

  • 1. Harnessing potential role of gangliosides in immunomodulation and cancer therapeutics.
    Hegde M; Girisa S; Aswani BS; Alqahtani MS; Abbas M; Sethi G; Kunnumakkara AB
    Life Sci; 2024 Aug; 351():122786. PubMed ID: 38848944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gangliosides as therapeutic targets for cancer.
    Fredman P; Hedberg K; Brezicka T
    BioDrugs; 2003; 17(3):155-67. PubMed ID: 12749752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting
    Fleurence J; Fougeray S; Bahri M; Cochonneau D; Clémenceau B; Paris F; Heczey A; Birklé S
    J Immunol Res; 2017; 2017():5604891. PubMed ID: 28154831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current state-of-the-art on ganglioside-mediated immune modulation in the tumor microenvironment.
    van der Haar Àvila I; Windhouwer B; van Vliet SJ
    Cancer Metastasis Rev; 2023 Sep; 42(3):941-958. PubMed ID: 37266839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulated Expression of Glycolipids in Tumor Cells: From Negative Modulator of Anti-tumor Immunity to Promising Targets for Developing Therapeutic Agents.
    Daniotti JL; Lardone RD; Vilcaes AA
    Front Oncol; 2015; 5():300. PubMed ID: 26779443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of gangliosides in active immunotherapy with melanoma vaccine.
    Ravindranath MH; Morton DL
    Int Rev Immunol; 1991; 7(4):303-29. PubMed ID: 1779175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy.
    Durrant LG; Noble P; Spendlove I
    Clin Exp Immunol; 2012 Feb; 167(2):206-15. PubMed ID: 22235996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gangliosides: Structures, Biosynthesis, Analysis, and Roles in Cancer.
    Groux-Degroote S; Guérardel Y; Delannoy P
    Chembiochem; 2017 Jul; 18(13):1146-1154. PubMed ID: 28295942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular recognition of gangliosides and their potential for cancer immunotherapies.
    Krengel U; Bousquet PA
    Front Immunol; 2014; 5():325. PubMed ID: 25101077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbohydrate antigens as targets for active specific immunotherapy.
    Ragupathi G
    Cancer Immunol Immunother; 1996 Nov; 43(3):152-7. PubMed ID: 9001568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of tumor-associated gangliosides in cancer progression.
    Birklé S; Zeng G; Gao L; Yu RK; Aubry J
    Biochimie; 2003; 85(3-4):455-63. PubMed ID: 12770784
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Cavdarli S; Delannoy P; Groux-Degroote S
    Cells; 2020 Mar; 9(3):. PubMed ID: 32192217
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeting of tumor-associated gangliosides with antibodies affects signaling pathways and leads to cell death including apoptosis.
    Horwacik I; Rokita H
    Apoptosis; 2015 May; 20(5):679-88. PubMed ID: 25673107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Naturally Occurring Human Antibodies Against Gangliosides by ELISA.
    Hernández AM; Rodríguez-Zhurbenko N
    Methods Mol Biol; 2017; 1643():179-186. PubMed ID: 28667538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-Associated Glycosphingolipids as Tumor Markers and Targets for Cancer Immunotherapy.
    Groux-Degroote S; Delannoy P
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with Tumor-Ganglioside Glycomimetics Activates a Selective Immunity that Affords Cancer Therapy.
    Tong W; Maira M; Roychoudhury R; Galan A; Brahimi F; Gilbert M; Cunningham AM; Josephy S; Pirvulescu I; Moffett S; Saragovi HU
    Cell Chem Biol; 2019 Jul; 26(7):1013-1026.e4. PubMed ID: 31105061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Northern hybridization analysis of VH gene expression in murine monoclonal antibodies directed to cancer-associated ganglioside antigens having various sialic acid linkages.
    Zenita K; Hirashima K; Shigeta K; Hiraiwa N; Takada A; Hashimoto K; Fujimoto E; Yago K; Kannagi R
    J Immunol; 1990 Jun; 144(11):4442-51. PubMed ID: 2111348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer vaccines: an update with special focus on ganglioside antigens.
    Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
    Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aiming for the Sweet Spot: Glyco-Immune Checkpoints and γδ T Cells in Targeted Immunotherapy.
    Bartish M; Del Rincón SV; Rudd CE; Saragovi HU
    Front Immunol; 2020; 11():564499. PubMed ID: 33133075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gangliosides as Signaling Regulators in Cancer.
    Sasaki N; Toyoda M; Ishiwata T
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34064863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.